Windlas Biotech Share Price (WINDLAS)
Check the latest share price of Windlas Biotech, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Windlas Biotech Stock Performance
Get live Windlas Biotech share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹906Day's Price Range₹935.4552 Week's Low
52 Week's High
₹652.7552-Week Price Range₹1,198.25
| Returns % | |
| 1 Month Return | -7.16 % |
| 3 Month Return | + 6.81 % |
| 1 Year Return | + 28.74 % |
| 3 Year Return | + 328.46 % |
| 5 Year Return | + 129.04 % |
| Market Stats | |
| Previous Close | ₹930.65 |
| Open | ₹906.00 |
| Volume | 34.76K |
| Upper Circuit | ₹1,116.75 |
| Lower Circuit | ₹744.55 |
Windlas Biotech Fundamentals & Key Indicators
Check Windlas Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,949.06 Cr
Return on Equity (ROE)
13.63
PE Ratio (TTM)
31.96
Return on capital employed (ROCE)
18.03
Industry PE ratio
57.39
Beta (LTM)
1.22
P/B Ratio
2.37
Dividend Yield
1.07
PEG Ratio
26.41
Quarterly Earnings Growth YOY
-4.18
EPS (TTM)
27.98
Sector
Pharmaceuticals
Book Value
216.34
Technical Analysis
Bullish
View Technical Analysis
How to invest in Windlas Biotech?
Investing in Windlas Biotech is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Windlas Biotech or WINDLAS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Windlas Biotech or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Windlas Biotech with just a few clicks!
Windlas Biotech Stock's Interest Amongst Investors
Windlas Biotech Valuation
Track how Windlas Biotech P/E has moved over time to understand its valuation trends.
Windlas Biotech in the last 5 years
Lowest (10.46x)
March 28, 2023
Today (31.96x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (38.93x)
December 6, 2024
Today’s Price to Earnings Ratio: 31.96x
Windlas Biotech Financial Results
Get the annual and quarterly financial summary of Windlas Biotech, including revenue, profit, loss and more.
Indices Featuring Windlas Biotech Stock
Check stock indices that include Windlas Biotech.
Windlas Biotech Earnings and Dividends
View detailed summary of the earnings and dividend history of Windlas Biotech.
Windlas Biotech Ltd Earnings Results
Windlas Biotech Ltd’s net profit fell -4.18% since last year same period to ₹16.28Cr in the Q4 2024-2025. On a quarterly growth basis, Windlas Biotech Ltd has generated 4.49% jump in its net profits since last 3-months.
Read More about Earnings ResultsWindlas Biotech Ltd Dividends May,2024
In the quarter ending March 2024, Windlas Biotech Ltd has declared dividend of ₹5.50 - translating a dividend yield of 0.59%.
Read More about Dividends
Windlas Biotech Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Windlas Biotech.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 62.34% | 0.00 | |
| Foreign Institutions | 1.52% | 0.00 | |
| Mutual Funds | 6.7% | 0.00 | |
| Retail Investors | 25.25% | 0.00 | |
| Others | 4.19% | 0.00 |
Windlas Biotech vs Peers
Compare market cap, revenue, PE, and other key metrics of Windlas Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 | |
| NA | 375.28 | 30.71% | 0.51 | NA | NA |
Windlas Biotech News & Key Events
Latest news and events in one place to help you make informed investing decisions in Windlas Biotech.
Windlas Biotech Reports Mixed Financial Results - 27 May, 2025
Windlas Biotech's consolidated net sales for March 2025 reached Rs 202.71 crore, up 18.34% year-on-year. However, net profit declined by 4.19% to Rs 16.28 crore, and EPS decreased to Rs 7.77 from Rs 8.17. EBITDA increased by 15.27%.Windlas Biotech Faces Decline Amid Market Trends - 23 May, 2025
Windlas Biotech Ltd has experienced a 9.89% decline over the past month, underperforming the BSE Healthcare index and SENSEX. The stock fell 4.88% today, trading at Rs 923, after reaching a record high of Rs 1197 on November 6, 2024, and a 52-week low of Rs 552.85 on June 4, 2024.
Insights on Windlas Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 15.58 Cr → 16.28 Cr (in ₹), with an average increase of 4.3% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 10 quarters, 121.87 Cr → 207.64 Cr (in ₹), with an average increase of 5.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 16.6%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 25.68% to 25.25% in Mar 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 7.11% to 6.70% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 62.51% to 62.34% in Mar 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, WINDLAS stock has moved down by -7.2%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 1.55% to 1.52% in Mar 2025 quarter
About Windlas Biotech
Revenue: ₹202.71Cr as on March 2025 (Q4 FY25)
Net Profit: ₹16.28Cr as on March 2025 (Q4 FY25)
Listing date: 16 Aug, 2021
Chairperson Name: Vivek Dhariwal
| Organisation | Windlas Biotech Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| CEO | Vivek Dhariwal |
| E-voting on shares | Click here to vote |
Mutual Funds that own Windlas Biotech
Check out the Mutual Funds with significant holdings in Windlas Biotech.
FAQs
What is Windlas Biotech share price today?
Windlas Biotech share price today stands at ₹932.55, Open: ₹906, Previous Close: ₹930.65, High: ₹935.45, Low: ₹906, 52 Week High: ₹1198.25, 52 Week Low: ₹652.75.
What is today's traded volume of Windlas Biotech?
Today's traded volume of Windlas Biotech is 34.76K. Which means that 34.76K shares of Windlas Biotech were bought and sold on the stock market during today's trading session.
What is Windlas Biotech's market cap today?
Today's market capitalisation of Windlas Biotech is ₹1,949.06 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Windlas Biotech?
Windlas Biotech’s 52 week high is ₹1198.25 and 52 week low is ₹652.75. The current share price of Windlas Biotech is ₹932.55, which is -22.17% down from its 52 week high and 42.86% up from its 52 week low.